The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,278,090 in first-year total cost, median $359,978.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-S (J2)]1
- Special Emphasis Panel[ZDK1 GRB-S (M2)]1
- Special Emphasis Panel[ZDK1 GRB-S (O2)]1
- ZDK1-GRB-S(O2)S1
Most frequent institutions
- JOSLIN DIABETES CENTER1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- UNIVERSITY OF ROCHESTER1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Cardiac Autoantibodies as Biomarkers for Heart Disease in Type 1 Diabetes1R01DK103609-01A1 | LIPES, MYRA A | JOSLIN DIABETES CENTER, MA | $372,330 | ZDK1 |
| 2016 | The Role of Anti-Serpin B13 Autoantibody as a Biomarker of Slower Progression in Type 1 Diabetes Mellitus1R56DK108739-01A1 | CZYZYK, JAN | UNIVERSITY OF ROCHESTER, NY | $153,583 | ZDK1 |
| 2015 | Molecular signatures of diabetic kidney disease1R01DK104706-01 | AFKARIAN, MARYAM | UNIVERSITY OF WASHINGTON, WA | $404,552 | ZDK1 |
| 2015 | Urinary Renin Angiotensin System in Diabetes1R01DK104785-01A1 | BATLLE, DANIEL | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $347,625 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.